Role of the Fc region in CD70-specific antibody effects on cardiac transplant survival

Transplantation

Volumn 92, Issue 11, 2011, Pages 1194-1201

  Shariff, Hina ^a   Greenlaw, Roseanna E ^a   Meader, Lucy ^a   Gardner, Nicola ^a   Yagita, Hideo ^b   Coccia, Marco ^c   Mamode, Nizam ^d   Jurcevic, Stipo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Medarex Inc   (United States)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibody therapy; CD70; Fc region; Heart transplantation

Indexed keywords

ALLOANTIBODY; CD70 ANTIGEN; FC RECEPTOR; HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FR 70; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA MATCHING; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; WILD TYPE;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD70; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; ISOANTIBODIES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; TREATMENT OUTCOME;

EID: 81855185925     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182347ecd     Document Type: Article

References (32)

1. Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010; 10: 301.
2. Grewal IS. CD70 as a therapeutic target in human malignancies. Expert Opin Ther Targets 2008; 12: 341.
3. McKeage K, McCormack PL. Basiliximab: A review of its use as induction therapy in renal transplantation. BioDrugs 2010; 24: 55.
4. Oflazoglu E, Boursalian TE, Zeng W, et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol 2009; 183: 3770.
5. Law CL, McEarchern JA, Grewal IS. Novel antibody-based therapeutic agents targeting CD70: A potential approach for treating Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma 2009; 9: 90.
6. Tesselaar K, Xiao Y, Arens R, et al. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 2003; 170: 33.
7. Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005; 17: 275.
8. Hendriks J, Gravestein LA, Tesselaar K, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000; 1: 433.
9. Dolfi DV, Boesteanu AC, Petrovas C, et al. Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+T cells. J Immunol 2008; 180: 2912.
10. Lee WW, Yang ZZ, Li G, et al. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 2007; 179: 2609.
11. Han BK, White AM, Dao KH, et al. Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus. Lupus 2005; 14: 598.
12. Nakajima A, Oshima H, Nohara C, et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2000; 109: 188.
13. Yamada A, Salama AD, Sho M, et al. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol 2005; 174: 1357.
14. Greenlaw RE, Gardner NJ, Farrar CA, et al. An antibody combination that targets activated T cells extends graft survival in sensitized recipients. Am J Transplant 2008; 8: 2272.
15. Shariff H, Tanriver Y, Brown KL, et al. Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients. Transplantation 2010; 90: 270.
16. Valujskikh A, Li XC. Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J Am Soc Nephrol 2007; 18: 2252.
17. Wu Z, Wang Y, Gao F, et al. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients. J Immunol 2008; 181: 1096.
18. Xiao Y, Peperzak V, Keller AM, et al. CD27 instructs CD4+ T cells to provide help for the memory CD8+ T cell response after protein immunization. J Immunol 2008; 181: 1071.
19. Matter M, Odermatt B, Yagita H, et al. Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med 2006; 203: 2145.
20. van Oosterwijk MF, Juwana H, Arens R, et al. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int Immunol 2007; 19: 713.
21. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, luminex binding antibodies-A new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
22. Rose ML, Smith JD. Clinical relevance of complement-fixing antibodies in cardiac transplantation. Hum Immunol 2009; 70: 605.
23. Wehner J, Morrell CN, Reynolds T, et al. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100: 191.
24. Deuse T, Hoyt G, Koyanagi T, et al. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778. Transplantation 2008; 85: 870.
25. Pescovitz MD. Rituximab, an anti-cd20 monoclonal antibody: History and mechanism of action. Am J Transplant 2006; 6 (5 Pt 1): 859.
26. Oshima H, Nakano H, Nohara C, et al. Characterization of murine CD70 by molecular cloning and mAb. Int Immunol 1998; 10: 517.
27. Feuerer M, Hill JA, Mathis D, et al. Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes. Nat Immunol 2009; 10: 689.
28. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest 2004; 114: 1398.
29. Waldmann H, Adams E, Fairchild P, et al. Regulation and privilege in transplantation tolerance. J Clin Immunol 2008; 28: 716.
30. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009; 9: 271.
31. McEarchern JA, Smith LM, McDonagh CF, et al. Preclinical characterization of SGN-70, a humanized antibody directed against CD70. Clin Cancer Res 2008; 14: 7763.
32. Niimi M. The technique for heterotopic cardiac transplantation in mice: Experience of 3000 operations by one surgeon. J Heart Lung Transplant 2001; 20: 1123.